Date	Chamber	Action
3/21/2025	House	Rule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance

215 ILCS 5/356u

Synopsis As Introduced
Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination). Effective January 1, 2027.

Actions 

Date	Chamber	Action
2/6/2025	House	Filed with the Clerk by Rep. Norine K. Hammond
2/6/2025	House	First Reading
2/6/2025	House	Referred to Rules Committee
3/4/2025	House	Assigned to Insurance Committee
3/12/2025	House	To Insurance Main Subcommittee
3/21/2025	House	Rule 19(a) / Re-referred to Rules Committee

Back To Top